• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT MITRACLIP XTR DELIVERY SYSTEM; MITRACLIP DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT MITRACLIP XTR DELIVERY SYSTEM; MITRACLIP DELIVERY SYSTEM Back to Search Results
Catalog Number CDS0602-XTR
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Cardiac Arrest (1762); Dyspnea (1816); Edema (1820); Low Blood Pressure/ Hypotension (1914); Nausea (1970); Renal Failure (2041); Heart Failure (2206)
Event Date 04/02/2019
Event Type  Death  
Manufacturer Narrative
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.The device is not returning for analysis.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
This report is filed due to worsening heart failure, cardiopulmonary arrest, and death.It was reported that on (b)(6) 2019, a mitraclip procedure was performed in a patient with cardiomyopathy and mixed mitral regurgitation (mr) with pure annular dilatation and an anterior leaflet prolapse.Two mitraclips were implanted without a device issue, reducing the mr from grade 4+ to 2+.On (b)(6) 2019, the patient was discharged home.On (b)(6) 2019, the patient was hospitalized for worsening heart failure, dyspnea, and peripheral edema.Diagnostics were performed and medication was provided.Reportedly, on (b)(6) 2019, an echocardiogram was performed.Although incomplete, per physician, the mitraclip had remained in situ, was well seated, and there was no tissue damage due to the clips.Left ventricular function was decreased.Diuretics were increased.On (b)(6) 2019, the patient was hospitalized again for worsening heart failure.The patient also experienced nausea, vomiting, dehydration, hypotension, and acute on chronic renal failure.The patient became hypotensive during the night of (b)(6) 2019, despite fluids provided.The patient was transferred to intensive care and inotropic medications were provided.Some improvement was noted.On (b)(6) 2019, sudden cardiorespiratory arrest occurred, and the patient had gone into pulseless electrical activity.The patient had a no-resuscitation status so no cardiopulmonary resuscitation was performed.Subsequently, the patient expired.No autopsy was performed.Per physician, the cause of death was most likely due to acute renal failure along with non-compaction cardiomyopathy (also known as spongiform cardiomyopathy), although acute mr cannot be ruled out as causative.No additional information was provided regarding this issue.
 
Manufacturer Narrative
(b)(4).The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.It should be noted that the reported patient effects of death, cardiac arrest, dyspnea, edema, hypotension, nausea, renal failure, heart failure, as listed in the mitraclip system instructions for use are known possible complications associated with mitraclip procedures.Based on the information reviewed, a conclusive cause for the reported patient effects of worsening heart failure, dyspnea, hypotension and renal failure and peripheral edema could not be determined.It is possible it was related to the patient morphology/pathology; however, it cannot be definitively confirmed.Cardiorespiratory arrest was a result of the underlying clinical /patient condition (combined effects of the patient effects).The cause of death was most likely due to acute renal failure along with non-compaction cardiomyopathy.Although a conclusive cause for the reported patient effect(s), and the relationship to the device, if any, cannot be determined, there is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITRACLIP XTR DELIVERY SYSTEM
Type of Device
MITRACLIP DELIVERY SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer (Section G)
MENLO PARK, CA REG# 3005070406
abbott vascular
26531 ynez rd.
temecula CA 92591 4628
Manufacturer Contact
connie speck
abbott vascular
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key8565516
MDR Text Key143573304
Report Number2024168-2019-03416
Device Sequence Number1
Product Code NKM
Combination Product (y/n)N
Reporter Country CodeNL
PMA/PMN Number
P100009
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,s
Reporter Occupation Physician
Remedial Action Other
Type of Report Initial,Followup
Report Date 07/11/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/07/2019
Device Catalogue NumberCDS0602-XTR
Device Lot Number81207U101
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/10/2019
Initial Date FDA Received04/30/2019
Supplement Dates Manufacturer Received06/19/2019
Supplement Dates FDA Received07/11/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/01/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
1 IMPLANTED MITRACLIP
Patient Outcome(s) Death;
Patient Age75 YR
Patient Weight54
-
-